Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors

Medicine & Life Sciences

• Bifidobacterium bifidum 100%
• Rotavirus 71%
• Gastroenteritis 68%
• Protective Factors 66%
• Oral Administration 53%
• Homeostasis 45%
• Rotavirus Infections 42%
• Diarrhea 20%
• Small Intestine 16%
• Gene Expression 11%
• villin 9%
• Rehydration Solutions 9%
• Claudin-1 8%
• Water 8%
• Occludin 8%
• Osmotic Pressure 7%
• Goblet Cells 7%
• Large Intestine 7%
• Fluid Therapy 7%
• Therapeutics 7%
• Mucins 6%
• Dehydration 6%
• Probiotics 6%
• Feces 6%
• Health Care Costs 5%
• Epidemics 5%
• Permeability 5%
• Nutrients 5%
• Child 2%
• Pharmaceutical Preparations 2%

Agriculture & Biology

• Bifidobacterium bifidum 87%
• Rotavirus 75%
• gastroenteritis 75%
• oral administration 63%
• homeostasis 53%
• therapeutics 23%
• diarrhea 19%
• small intestine 14%
• infection 13%
• gene expression 9%
• oral rehydration 8%
• malabsorption 7%
• goblet cells 6%
• mucins 5%
• large intestine 5%
• osmotic pressure 5%
• suckling 5%
• shortenings 5%
• protective effect 4%
• probiotics 4%
• signs and symptoms (animals and humans) 4%
• water uptake 4%
• animal models 4%
• permeability 4%
• digestive system 4%
• feces 4%
• lesions (animal) 4%
• drugs 3%
• nutrients 3%
• mice 2%
• water 2%
• methodology 1%

Chemical Compounds

• Protective 51%
• Osmotic Pressure 25%
• Shortening 22%
• Nutrient 21%
• Dehydration 17%
• Permeability 16%
• Drug 10%
• Mixture 8%